Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
JAZZ
JAZZ
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JAZZ News
Biotech Sector Sees FDA Approvals and Layoffs
2d ago
NASDAQ.COM
Jazz Pharmaceuticals and AbCellera Collaborate on Antibody Development
4d ago
NASDAQ.COM
Jazz Pharmaceuticals and AbCellera Sign $848M Agreement for Antibody Development
4d ago
seekingalpha
Jazz Pharmaceuticals Partners with AbCellera for Antibody Development
4d ago
PRnewswire
Jazz Pharmaceuticals Partners with AbCellera for Antibody Development
4d ago
Newsfilter
Jazz Pharmaceuticals Unveils New Research Advances at SLEEP 2026
4d ago
PRnewswire
Jazz Pharmaceuticals Q1 Earnings Analysis and Investment Recommendations
5d ago
Yahoo Finance
Jazz Pharmaceuticals' LAGOON Trial Results Fail to Meet Expectations
Jun 12 2026
NASDAQ.COM
Jazz Pharmaceuticals' Zepzelca Fails Phase 3 Trial Endpoint
Jun 12 2026
NASDAQ.COM
Jazz Pharmaceuticals' Lung Cancer Therapy Trial Fails
Jun 12 2026
seekingalpha
Jazz Pharmaceuticals Announces LAGOON Trial Results for Zepzelca
Jun 12 2026
PRnewswire
Jazz Pharmaceuticals' LAGOON Trial Results Fail to Meet Primary Endpoint
Jun 12 2026
Newsfilter
Jazz Pharmaceuticals Presents 21 Abstracts at SLEEP 2026 Conference
Jun 04 2026
PRnewswire
Zanidatamab Shows Breakthrough Efficacy in HER2-Positive Cancer Treatments
May 27 2026
PRnewswire
Zanidatamab Shows Breakthrough Efficacy in HER2-Positive Cancer
May 27 2026
Newsfilter
UBS Upgrades Jazz Pharmaceuticals to Buy, Highlights Ziihera's Potential
May 19 2026
seekingalpha
Show More News
